PLX
Protalix BioTherapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$2.83
+0.04 ▲ +1.43%
🌙 3월 13일 7:59 PM ET (한국 3/14 08:59)
$2.79
-0.04 ▼ -1.41%
| Index | RUT | P/E | 40.72 | EPS (ttm) | 0.07 | Insider Own | 10.56% | Shs Outstand | 0.08B | Perf Week | 8.02% |
| Market Cap | 0.23B | Forward P/E | 14.15 | EPS next Y | 566.67% | Insider Trans | 0.66% | Shs Float | 0.07B | Perf Month | -3.08% |
| Enterprise Value | 0.21B | PEG | - | EPS next Q | 0.04 | Inst Own | 25.41% | Short Float | 5.8% | Perf Quarter | 57.22% |
| Income | 0.01B | P/S | 3.68 | EPS this Y | -25% | Inst Trans | - | Short Ratio | 3.52 | Perf Half Y | 62.64% |
| Sales | 0.06B | P/B | 4.3 | EPS next 5Y | - | ROA | 7.5% | Short Interest | 4.17M | Perf YTD | 57.22% |
| Book/sh | 0.66 | P/C | 7.75 | EPS past 3/5Y | - | ROE | 12.64% | 52W High | -11.29% ($3.19) | Perf Year | 30.41% |
| Cash/sh | 0.37 | P/FCF | - | Sales past 3/5Y | 11.67% -0.48% | ROIC | 9.04% | 52W Low | 114.39% ($1.32) | Perf 3Y | 51.34% |
| Dividend Est. | - | EV/EBITDA | 26.53 | EPS Y/Y TTM | 153.26% | Gross Margin | 57.54% | Volatility(W/M) | 4.61% 5.24% | Perf 5Y | -41.65% |
| Dividend TTM | - | EV/Sales | 3.34 | Sales Y/Y TTM | 35.42% | Oper. Margin | 10.3% | ATR (14) | 0.15 | Perf 10Y | -68.9% |
| Dividend Ex-Date | - | Quick Ratio | 2.06 | EPS Q/Q | -13.39% | Profit Margin | 8.72% | RSI (14) | 52.12 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.03 | Sales Q/Q | -0.6% | SMA20 | -3.38% ($2.93) | Beta | -0.22 | Target Price | $12 |
| Payout | - | Debt/Eq | 0.15 | Earnings | 3000000 | SMA50 | 12.25% ($2.52) | Rel Volume | 0.6 | Prev Close | $2.79 |
| Employees | 213 | LT Debt/Eq | 0.13 | EPS/Sales Surpr. | -45.45% -0.19% | SMA200 | 43.64% ($1.97) | Avg Volume(3M) | 1.19M | Price | $2.83 |
| IPO | 1996/4/9 | Option/Short | Yes/Yes | Trades | 2580 | Volume | 705,595 | Change | 1.43% |
뉴스 로딩 중...